Silybin A in Immunometabolic Research: Beyond Hepatoprotecti
2026-08-03
Explore how Silybin A, a principal component of Silymarin, is shaping advanced immunometabolic research through its effects on inflammation, autophagy, and metabolic enzyme modulation. This article delivers unique insights into experimental design and translational potential not covered by standard hepatoprotective content.
Prostaglandin E2: Mechanistic Insights & Strategic Leverage
2026-08-02
This article provides translational researchers with a mechanistic and strategic overview of Prostaglandin E2 (PGE2), highlighting its receptor-specific signaling, multi-domain applications, and practical guidance for integrating PGE2 into innovative workflows such as pancreatic organoid modeling. The discussion bridges recent advances in organoid technology with actionable protocol recommendations and translational relevance, positioning APExBIO’s high-purity PGE2 as a cornerstone for next-generation inflammation research and regenerative medicine.
MTT in Endothelial Angiogenesis: Mechanistic Insights for In
2026-08-01
Explore how MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) enables advanced assessment of endothelial cell angiogenesis and viability. This article uniquely bridges in vitro colorimetric assay mechanisms with recent discoveries in vascular biology, providing actionable guidance for translational research.
Araucarene Diterpenes from Agathis dammara Promote β Cell Re
2026-07-31
This study isolates and characterizes 16 araucarene diterpenoids from Agathis dammara, including 11 new molecules, and demonstrates their hypoglycemic effects through enhanced pancreatic β cell regeneration and glucose uptake in zebrafish. These findings provide a mechanistic basis for exploring diterpenes in diabetes research and metabolic disease therapeutics.
CTP Solution Enhances In Vitro Transcription for mRNA-LNP Th
2026-07-31
CTP Solution (100 mM) delivers unmatched nucleotide purity for high-yield, low-immunogenicity mRNA synthesis—essential for next-gen cancer therapeutics. Discover how this reagent streamlines workflows, powers robust in vitro transcription, and addresses pitfalls in RNA amplification for lipid nanoparticle delivery.
XPO1 Inhibition Enhances Platinum Sensitivity in GCB-DLBCL C
2026-07-30
This study demonstrates that XPO1 inhibition, using agents such as Selinexor, can significantly improve the efficacy of platinum-based chemotherapy in germinal-center B-cell-like diffuse large B-cell lymphoma (GCB-DLBCL) models. The findings support the strategic combination of XPO1 inhibitors with platinum compounds to tackle chemoresistance in aggressive lymphoma subtypes.
TPCA-1: Precision IKK-2 Inhibitor Workflows for Inflammation
2026-07-30
TPCA-1 enables researchers to dissect the NF-κB axis with extraordinary selectivity, supporting robust cytokine suppression and disease modeling. This guide delivers actionable protocols, troubleshooting insights, and cross-assay enhancements for inflammation and acute kidney injury workflows.
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
2026-07-29
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for efficient amide bond formation in peptide synthesis and bioconjugation workflows. It should be used exclusively in in vitro protocols, as there is no supporting data for in vivo or clinical applications.
Eicosapentaenoic Acid (EPA): Beyond Lipids to Immune Modulat
2026-07-29
Explore the multidimensional role of Eicosapentaenoic Acid (EPA) omega-3 fatty acid in cardiovascular and immune research. This article uniquely bridges membrane biology, lipid-lowering efficacy, and immunomodulatory mechanisms, offering advanced protocol guidance for translational scientists.
Necrostatin-1: Precision RIP1 Kinase Inhibition in Necroptos
2026-07-28
Necrostatin-1 enables precise, selective inhibition of RIP1 kinase, empowering researchers to dissect necroptosis and inflammation pathways in disease models. With data-driven protocols and troubleshooting tips, this guide accelerates translational discovery in acute injury and cell death research.
Thiazovivin (A5506): ROCK Inhibitor for Stem Cell Workflows
2026-07-28
Thiazovivin is a selective ROCK inhibitor optimized for enhancing induced pluripotent stem cell (iPSC) generation and supporting human embryonic stem cell (hESC) survival after dissociation. It should be used in research workflows requiring robust cell viability and reprogramming efficiency, but is not suitable for diagnostic or medical applications. Long-term storage of prepared solutions and off-label clinical use are not recommended.
Phosbind Biotin: Redefining Phosphorylated Protein Detection
2026-07-27
Explore how Phosbind Biotin, leveraging dinuclear metal complex phosphate binding, sets a new benchmark for Western Blot detection of phosphorylated proteins. This article uniquely dissects its mechanism, practical protocol choices, and insights from recent plant stress research.
PF-562271 HCl: Precision Tools for FAK/Pyk2 Inhibition in Ca
2026-07-27
Explore how PF-562271 HCl, a potent FAK/Pyk2 inhibitor, advances cancer research through exceptional selectivity and protocol flexibility. This in-depth analysis highlights key assay design insights and practical considerations for maximizing experimental success.
Scenario-Based Insights: FITC Goat Anti-Mouse IgG (H+L) Anti
2026-07-26
This article delivers scenario-driven, evidence-based guidance for using the FITC Goat Anti-Mouse IgG (H+L) Antibody (SKU K1201) in cell viability and immunofluorescence assays. Designed for biomedical researchers and lab technicians, it details how this fluorescein-conjugated secondary antibody enhances reproducibility, sensitivity, and workflow security in mouse IgG detection.
AI-10-49: Transforming CBFβ-SMMHC Inhibition in AML Research
2026-07-25
AI-10-49, a selective CBFβ-SMMHC inhibitor, enables precision targeting of leukemic fusion proteins and restoration of RUNX1 function. This article provides a practical, data-driven walkthrough for integrating AI-10-49 into acute myeloid leukemia research workflows, with actionable protocol guidance and troubleshooting strategies.
463 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page